
|Articles|May 1, 1997
The American Journal of Managed Care
- May 1997
- Volume 3
- Issue 5
Economic Winners and Losers After Introduction of an Effective New Therapy Depend on the Type of Payment System
Advertisement
Articles in this issue
over 28 years ago
Clinical Considerations in GERD Therapy: Focus on Cisaprideover 28 years ago
Health Outcomes and Managed Care: Discussing the Hidden Issuesover 28 years ago
Diagnosis and Treatment of Chronic Renal Failure in ChildrenNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
5 Consequences If ACA Premium Subsidies End in 2026
2
Raludotatug Deruxtecan Demonstrates Promising Efficacy, Safety in Platinum-Resistant Ovarian Cancer
3
Team-Based Precision Oncology: Advancing Value and Access in Cancer Care
4
Navigating Costs and Logistics of Cellular Therapies, ADCs, and Novel Diagnostics in Cancer Care
5















































